FDA Investigator Emily S Mcgann

Emily S Mcgann has conducted inspections on 41 sites in 1 countries as of 20 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
41
Last Inspection Date:
20 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Emily S Mcgann:
Abby Lmozeke Baker, Adam J Taylor, Albert F Peacock, PhD, Amanda S Zorn, Amy A Johnson, Amy C Amaro, Ana Djurdjevic, Ana L Kewes, Anthony N Onianwa, Anya Dlockett Evans, Armando Chavez, MS, Arsen Karapetyan, Blondell W Johnson, Brentley S Collins, Bryce A May, Charles L Larson, Clotia Cabbey Mensah, Connie L Hannon Rabel, Conor J Mccarron, Cordelia J Brammer, Darla J Christopher, Debra I Love, Decarlos A Gomez, Denise L Burosh, Dennis M Farley, Diana L Ayala, Diana M Rand, Ellen C Weisensel, Elmina E Akwo, Elmina E Mboh, Emily B Camire, Ernest Serna, III, Esra Toussaint, Everard A Irish, Gabriel M Guevarra, Gabryelle J Solverud, Garrad R Poole, Gene D Arcy, Gloria A Milster, Hoimay Chan, Humera T Khan, Jason F Chancey, Jeanne J Chiu, Jeanne J Thai, Jennifer C Adams, Jennifer C Johnson, Jesse P Romenesko, Jocelyn C Turner, Justin A Boyd, Ka L Wong, Kaarin M Slotte, Kelly D Moore, Kenneth S Boehnen, Kimberly Cdelk Brooks, Kip J Hanks, Lana K Waselewski, Lauren A Crivellone, Laurissa S Flowers, Lee Terry Moore, Lequita M Mayhew, Leslie W Gilbert, Lillie M Young, Lorie S Hannappel, LTJG Bradley E Benasutti, Maira P Brading, Marion W Nadeau, Mary Ewilkerson Brinsko, Maryann Ruff, Matthew J Gretkierewicz, Matthew J Sienko, Melissa D Kalik, Melissa J Holz, Michael I Gorman, Michael N Roberts, Michelle J Glembin, Monique S Frazier, Nathan R Moon, Nicholas M Smith, Patricia A Mcilroy, Patricia M Jacobs, Paul M Chefor, Richard L Bartlett, Robert M Tillman, Robert S Sweeton, Roberta W Cunningham, Ronda Rloyd Jones, Rose Ashley, Rosia E Nesbitt, Sarah A Palmer, Shalonda C Clifford, Sunitha K Rajaram, PhD, Susan M Miller, Susan M North, Tania Y Hall, Tawny L Colling, Terrance L Thomas, Thanh B Tran, Toby Vern H Hill, Todd M Stankewicz, Tonia L Sawyer, Travis R Hunt, Travis S Bradley, Uruaku A Obasi, Vanessa R Muller, Vien Q Le, William F Lagud, Jr, Young M Yoon, Yvonne C Wilkes, Yvonne E Lozano, Yvonne T Lacour, Zerita White

Emily S Mcgann's Documents

Publish Date Document Type Title
March, 2022 FDA 483 Hendrick Regional Laboratory Transfusion Services - Form 483, 2022-03-10
August, 2023 FDA 483 Fertility Center of Orange County, A Medical Group Inc. - Form 483, 2023-08-29
July, 2023 FDA 483 Pelex Medical of Texas - Form 483, 2023-07-28
March, 2023 FDA 483 CSL Plasma Inc. - Form 483, 2023-03-29
June, 2023 FDA 483 Arizona Center for Reproductive Endocrinology & Infertility - Form 483, 2023-06-28
August, 2023 FDA 483 Pacific Reproductive Center, Inc. - Form 483, 2023-08-31
January, 2023 FDA 483 BPL Plasma, Inc. - Form 483, 2023-01-26
September, 2023 FDA 483 Re-Gen Active Lab Inc - Form 483, 2023-09-21
March, 2024 FDA 483 Eurofins Donor & Product Testing Inc Dallas - Form 483, 2024-03-05
June, 2022 EIR Donor Network of Arizona - EIR, 2022-06-06
February, 2024 FDA 483 BLS Labs, LLC - Form 483, 2024-02-09
September, 2022 FDA 483 Texas Tech University Health Sciences Center Center for Fertility and Reproductive Surgery - Form 483, 2022-09-21
January, 2024 FDA 483 CBR Systems Inc - Form 483, 2024-01-17
April, 2024 FDA 483 Applied Biologics LLC - Form 483, 2024-04-18
June, 2022 FDA 483 Arizona Center for Reproductive Endocrinology & Infertility - Form 483, 2022-06-22
July, 2023 FDA 483 Texas Tech University Health Sciences Center Center for Fertility and Reproductive Surgery - Form 483, 2023-07-26
March, 2022 FDA 483 Hendrick Regional Blood Center - Form 483, 2022-03-07
June, 2024 FDA 483 Eversight Illinois - Form 483, 2024-06-18

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more